Participated in a PGxAI seed round alongside ATEM Capital Fund LP, according to Crunchbase.
PGxAI is a configurable clinician-facing platform that surfaces drug-drug interactions, contraindications, and pharmacogenomic guidance from FDA-required labeling and established guidance sources for independent clinician review
PGxAI is a configurable clinician-facing platform that surfaces drug-drug interactions, contraindications, and pharmacogenomic guidance from FDA-required labeling and established guidance sources for independent clinician review.